Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Sci Rep ; 7(1): 12821, 2017 10 09.
Artigo em Inglês | MEDLINE | ID: mdl-28993663

RESUMO

Proteins involved in iron homeostasis have been identified as biomarkers for lupus nephritis, a serious complication of systemic lupus erythematosus (SLE). We tested the hypothesis that renal iron accumulation occurs and contributes to renal injury in SLE. Renal non-heme iron levels were increased in the (New Zealand Black x New Zealand White) F1 (NZB/W) mouse model of lupus nephritis compared with healthy New Zealand White (NZW) mice in an age- and strain-dependent manner. Biodistribution studies revealed increased transferrin-bound iron accumulation in the kidneys of albuminuric NZB/W mice, but no difference in the accumulation of non-transferrin bound iron or ferritin. Transferrin excretion was significantly increased in albuminuric NZB/W mice, indicating enhanced tubular exposure and potential for enhanced tubular uptake following filtration. Expression of transferrin receptor and 24p3R were reduced in tubules from NZB/W compared to NZW mice, while ferroportin expression was unchanged and ferritin expression increased, consistent with increased iron accumulation and compensatory downregulation of uptake pathways. Treatment of NZB/W mice with the iron chelator deferiprone significantly delayed the onset of albuminuria and reduced blood urea nitrogen concentrations. Together, these findings suggest that pathological changes in renal iron homeostasis occurs in lupus nephritis, contributing to the development of kidney injury.


Assuntos
Albuminúria/metabolismo , Quelantes de Ferro/farmacologia , Ferro/metabolismo , Rim/metabolismo , Lúpus Eritematoso Sistêmico/metabolismo , Albuminúria/urina , Animais , Deferiprona/farmacologia , Modelos Animais de Doenças , Proteínas de Ligação ao Ferro/metabolismo , Rim/efeitos dos fármacos , Rim/patologia , Túbulos Renais/efeitos dos fármacos , Túbulos Renais/metabolismo , Lúpus Eritematoso Sistêmico/urina , Camundongos , Distribuição Tecidual/efeitos dos fármacos , Transferrina/urina
2.
Cytokine ; 91: 38-43, 2017 03.
Artigo em Inglês | MEDLINE | ID: mdl-27997859

RESUMO

Neutrophil gelatinase-associated lipocalin (NGAL) is increasingly regarded as a biomarker of acute kidney injury, or kidney injury in general, but the stimuli responsible for its production are incompletely understood. This study tested the relationship between the pro-inflammatory cytokine interleukin-1ß (IL-1ß) and both circulating and renal NGAL, using chronic subcutaneous infusion of IL-1ß in mice and tissue culture of renal cell lines. Following a 14-day subcutaneous infusion of vehicle or IL-1ß (10ng/h) in male C57Bl/6 mice, a striking positive correlation (r2=0.94; P<0.01) was observed between plasma IL-1ß and NGAL concentrations. NGAL was markedly increased in the kidneys of IL-1ß-infused mice compared with vehicle-treated mice, both at the protein and mRNA level, indicating increased local as well as systemic production of NGAL. Immunohistochemical staining revealed prominent increases of NGAL in the proximal tubular epithelium of IL-1ß infused mice. These effects occurred in the absence of overt renal injury, with plasma creatinine concentration not significantly different between groups. Further showing that IL-1ß has a direct effect on NGAL production by tubular epithelial cells, exposure of a proximal tubular cell line (HK-2 cells) and a cortical collecting duct principal cell line (mpkCCD cells) to IL-1ß for 24h produced a significant increase of NGAL mRNA levels (>30-fold). These data indicate IL-1ß serves as a powerful stimulus for renal production of NGAL.


Assuntos
Injúria Renal Aguda/imunologia , Interleucina-1beta/imunologia , Túbulos Renais Proximais/imunologia , Lipocalina-2/imunologia , Injúria Renal Aguda/induzido quimicamente , Injúria Renal Aguda/patologia , Animais , Linhagem Celular Transformada , Humanos , Túbulos Renais Proximais/patologia , Camundongos
3.
Am J Physiol Renal Physiol ; 309(4): F305-17, 2015 Aug 15.
Artigo em Inglês | MEDLINE | ID: mdl-26062878

RESUMO

While there is evidence that sex hormones influence multiple systems involved in salt and water homeostasis, the question of whether sex hormones regulate aquaporin-2 (AQP2) and thus water handling by the collecting duct has been largely ignored. Accordingly, the present study investigated AQP2 expression, localization and renal water handling in intact and ovariectomized (OVX) female rats, with and without estradiol or progesterone replacement. OVX resulted in a significant increase in urine osmolality and increase in p256-AQP2 in the renal cortex at 7 days post-OVX, as well as induced body weight changes. Relative to OVX alone, estradiol repletion produced a significant increase in urine output, normalized urinary osmolality and reduced both total AQP2 (protein and mRNA) and p256-AQP2 expression, whereas progesterone repletion had little effect. Direct effects of estradiol on AQP2 mRNA and protein levels were further tested in vitro using the mpkCCD principal cell line. Estradiol treatment of mpkCCD cells reduced AQP2 at both the mRNA and protein level in the absence of deamino-8-d-AVP (dDAVP) and significantly blunted the dDAVP-induced increase in AQP2 at the protein level only. We determined that mpkCCD and native mouse collecting ducts express both estrogen receptor (ER)α and ERß and that female mice lacking ERα displayed significant increases in AQP2 protein compared with wild-type littermates, implicating ERα in mediating the inhibitory effect of estradiol on AQP2 expression. These findings suggest that changes in estradiol levels, such as during menopause or following reproductive surgeries, may contribute to dysregulation of water homeostasis in women.


Assuntos
Aquaporina 2/metabolismo , Estradiol/farmacologia , Receptor alfa de Estrogênio/agonistas , Terapia de Reposição de Estrogênios , Túbulos Renais Coletores/efeitos dos fármacos , Osmorregulação/efeitos dos fármacos , Animais , Aquaporina 2/genética , Linhagem Celular , Regulação para Baixo , Ingestão de Líquidos/efeitos dos fármacos , Ingestão de Alimentos/efeitos dos fármacos , Receptor alfa de Estrogênio/deficiência , Receptor alfa de Estrogênio/genética , Feminino , Túbulos Renais Coletores/metabolismo , Camundongos Endogâmicos C57BL , Camundongos Knockout , Concentração Osmolar , Ovariectomia , Fosforilação , Progesterona/farmacologia , Transporte Proteico , RNA Mensageiro/metabolismo , Ratos Wistar , Fatores de Tempo , Micção/efeitos dos fármacos , Aumento de Peso/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...